It redirects polyclonal T cells to target melanoma cells, and normal melanocytes, presenting a specific glycoprotein 100 (gp100) peptide (YLEPGPVTA) by HLA-A*02:01 on the cell surface (6, 7). The gene discussed is PMEL; the disease is melanoma.